Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Best Practice & Research. Clinical Haematology|September 16, 2008
Immunotherapy targeting EBV-expressing lymphoproliferative diseasesCatherine M Bollard, Laurence J Cooper, Helen E Heslop
Theranostics|June 1, 2019
Human LAP+GARP+FOXP3+ regulatory T cells attenuate xenogeneic graft versus host diseaseHuihui Wang, Hyo Song, Anha V Pham, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 23, 2010
Antitransgene rejection responses contribute to attenuated persistence of adoptively transferred CD20/CD19-specific chimeric antigen receptor redirected T cells in humansMichael C Jensen, Leslie Popplewell, Laurence J Cooper, et al.
The Journal of Clinical Investigation|May 17, 2016
CD62L+ NKT cells have prolonged persistence and antitumor activity in vivoGengwen Tian, Amy N Courtney, Bipulendu Jena, et al.
Oncogene|April 7, 2018
Antitumor activity of CD56-chimeric antigen receptor T cells in neuroblastoma and SCLC modelsDenise L Crossland, Warren L Denning, Sonny Ang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2018
Infusion of Alloanergized Donor Lymphocytes after CD34-selected Haploidentical Myeloablative Hematopoietic Stem Cell TransplantationJeff K Davies, Lisa L Brennan, John R Wingard, et al.
Immunotherapy|August 28, 2015
Strategies for combining immunotherapy with radiation for anticancer therapySteven N Seyedin, Jonathan E Schoenhals, Dean A Lee, et al.
Cytotherapy|October 8, 2013
Fucosylation with fucosyltransferase VI or fucosyltransferase VII improves cord blood engraftmentSimon N Robinson, Michael W Thomas, Paul J Simmons, et al.
Pageof 2